Universal Health Services, Inc. (UHS)
| Market Cap | 10.29B -9.0% |
| Revenue (ttm) | 17.76B +10.4% |
| Net Income | 1.52B +27.1% |
| EPS | 23.99 +34.8% |
| Shares Out | 60.54M |
| PE Ratio | 7.08 |
| Forward PE | 7.18 |
| Dividend | $0.80 (0.47%) |
| Ex-Dividend Date | Mar 2, 2026 |
| Volume | 1,109,717 |
| Open | 173.85 |
| Previous Close | 170.56 |
| Day's Range | 168.81 - 175.00 |
| 52-Week Range | 152.33 - 246.33 |
| Beta | 1.13 |
| Analysts | Buy |
| Price Target | 217.09 (+27.73%) |
| Earnings Date | Apr 27, 2026 |
About UHS
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities in the United States. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company’s hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric, pharmacy, and/or behavioral health services. It also provides commercial health insurance services; capita... [Read more]
Financial Performance
In 2025, Universal Health Services's revenue was $17.36 billion, an increase of 9.71% compared to the previous year's $15.83 billion. Earnings were $1.49 billion, an increase of 30.36%.
Financial StatementsAnalyst Summary
According to 11 analysts, the average rating for UHS stock is "Buy." The 12-month stock price target is $217.09, which is an increase of 27.73% from the latest price.
News
UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT BOFA SECURITIES HEALTH CARE CONFERENCE
KING OF PRUSSIA, Pa., April 30, 2026 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) is scheduled to present at the BofA Securities Health Care Conference on May 12, 2026, at 1:40pm PT.
Universal Health price target lowered to $310 from $320 at UBS
UBS lowered the firm’s price target on Universal Health (UHS) to $310 from $320 and keeps a Buy rating on the shares.
Universal Health price target lowered to $194 from $229 at Cantor Fitzgerald
Cantor Fitzgerald lowered the firm’s price target on Universal Health (UHS) to $194 from $229 and keeps a Neutral rating on the shares. Universal Health Services reported an in-line Q1
Universal Health price target lowered to $230 from $245 at TD Cowen
TD Cowen lowered the firm’s price target on Universal Health (UHS) to $230 from $245 and keeps a Buy rating on the shares. The firm updated its model following Q1
Universal Health price target lowered to $211 from $238 at Guggenheim
Guggenheim lowered the firm’s price target on Universal Health (UHS) to $211 from $238 and keeps a Buy rating on the shares. The story for the quarter “ultimately boiled down
Universal Health price target lowered to $190 from $216 at RBC Capital
RBC Capital lowered the firm’s price target on Universal Health (UHS) to $190 from $216 and keeps a Sector Perform rating on the shares. The company’s Q1 results came in
Universal Health price target lowered to $204 from $241 at Baird
Baird analyst Michael Ha lowered the firm’s price target on Universal Health (UHS) to $204 from $241 and keeps a Neutral rating on the shares. The firm updated its model
Universal Health downgraded to Market Perform from Outperform at Raymond James
Raymond James downgraded Universal Health (UHS) to Market Perform from Outperform without a price target The firm has concerns about the company’s ability EBITDA guidance throughout 2026. The low end
Universal Health Services Earnings Call Transcript: Q1 2026
Q1 2026 saw strong revenue and EPS growth, driven by disciplined operations, pricing, and the strategic Talkspace acquisition. Acute and behavioral segments delivered solid results despite seasonal headwinds, with continued investment in technology, new facilities, and capital returns.
Universal Health price target lowered to $238 from $268 at Barclays
Barclays lowered the firm’s price target on Universal Health (UHS) to $238 from $268 and keeps an Overweight rating on the shares following the Q1 report. The firm says that
UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THREE-MONTH PERIOD ENDED MARCH 31, 2026
Consolidated Results of Operations, As Reported and As Adjusted – Three-month periods ended March 31, 2026 and 2025: KING OF PRUSSIA, Pa., April 27, 2026 /PRNewswire/ -- Universal Health Services, In...
Universal Health options imply 5.8% move in share price post-earnings
Pre-earnings options volume in Universal Health (UHS) is 6.7x normal with calls leading puts 3:2. Implied volatility suggests the market is anticipating a move near 5.8%, or $10.34, after results
Universal Health price target lowered to $238 from $262 at Guggenheim
Guggenheim lowered the firm’s price target on Universal Health (UHS) to $238 from $262 and keeps a Buy rating on the shares.
UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DATE FOR FIRST QUARTER 2026 EARNINGS RELEASE AND CONFERENCE CALL
KING OF PRUSSIA, Pa., April 6, 2026 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that it will report results for its first quarter ended March 31, 2026, after the market...
Universal Health Services Transcript: Barclays 28th Annual Global Healthcare Conference
The acquisition of Talkspace is set to accelerate outpatient behavioral growth, expand reach to younger, commercially insured populations, and enhance the care continuum. AI investments are driving operational efficiencies and improved reimbursement, while stable employment trends and strategic labor investments support growth across segments.
M&A News: Talkspace Stock (TALK) Surges 8% after $835M UHS Acquisition to Keep Tackling U.S. Mental Health Crisis
Shares in behavioral healthcare provider Talkspace ($TALK) dialed higher today after it was bought by hospital operator Universal Health Services ($UHS) for $835 million to keep tackling the post-Covi...
Universal Health strikes $835 million Talkspace deal in mental health push
Hospital operator Universal Health Services said on Monday it would acquire virtual healthcare provider Talkspace in a deal valued at $835 million, amid rising demand for behavioral health services.
Universal Health Services Transcript: Leerink Global Healthcare Conference 2026
A major acquisition of Talkspace for $840 million is set to accelerate outpatient behavioral health growth, leveraging virtual care and a large therapist network. The deal is expected to be accretive, with ongoing investments in technology and AI to drive productivity and efficiency.
Universal Health to acquire Talkspace for $5.25 per share
07:40 EDT Universal Health (UHS) to acquire Talkspace (TALK) for $5.25 per share
Universal Health to acquire Talkspace for $5.25 per share
Universal Health Services (UHS) announced that it has entered into a definitive agreement to acquire Talkspace (TALK) for $5.25 per share. The enterprise value for the transaction is approximately $83...
Universal Health Services, Inc. to Acquire Talkspace, Inc.
Industry-leading virtual behavioral healthcare platform accelerates outpatient strategy with expanded access to care KING OF PRUSSIA, Pa. and NEW YORK, March 9, 2026 /PRNewswire/ -- Universal Health S...
Universal Health Services Transcript: TD Cowen 46th Annual Health Care Conference
Sequential EBITDA in acute care declined due to non-recurring items, but underlying performance was stable. Guidance for 2026 targets 2%-3% volume growth, with behavioral segment staffing investments and outpatient expansion. Regulatory changes, payer dynamics, and technology adoption are shaping financial and operational strategies.
Universal Health price target lowered to $212 from $235 at Wells Fargo
Wells Fargo lowered the firm’s price target on Universal Health (UHS) to $212 from $235 and keeps an Equal Weight rating on the shares. The firm notes results in Q4
Universal Health price target lowered to $229 from $250 at Cantor Fitzgerald
Cantor Fitzgerald lowered the firm’s price target on Universal Health (UHS) to $229 from $250 and keeps a Neutral rating on the shares.
Universal Health Services Earnings Call Transcript: Q4 2025
Q4 and full-year 2025 saw strong revenue and earnings growth, driven by expense management, volume gains, and technology adoption. 2026 guidance anticipates continued growth but includes headwinds from insurance exchange declines and new staffing regulations.